IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q4 2013 Holdings

Filed 2014-02-13 | 17 holdings | $13.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$13.3M1,754,35698.7%
GW PharmaceuticalsCOM36197T103$29.1K699,3760.2%
Anacor Pharmaceuticals IncCOM032420101$25.9K1,545,9990.2%
Ironwood Pharmaceuticals Inc(IRWD)COM46333X108$20.9K1,800,0000.2%
Dyax CorpCOM26746E103$19.5K2,586,9800.1%
Keryx Biopharmaceuticals IncCOM492515101$13.0K1,000,2730.1%
Heron TherapeuticsCOM00202J203$9.9K21,914,7000.1%
Ocera TherapeuticsCOM67552A108$9.1K703,7300.1%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$8.9K719,0750.1%
Chelsea Therapeutics International LtdCOM163428105$7.5K1,701,1700.1%
DBV TechnologiesCOMF2927N109$7.2K480,0000.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$6.5K694,9030.0%
TherapeuticsMD IncCOM88338N107$4.4K846,5000.0%
Tesaro IncCOM881569107$3.9K137,7490.0%
Biodel IncCOM09064M105$2.7K1,196,4920.0%
Hyperion Therapeutics IncCOM44915N101$2.2K109,2710.0%
Alexza Pharmaceuticals IncCOM015384100$1.8K374,9990.0%